Analysis of intestinal bacteria for patients with pancreatic exocrine secretion for precision medicine

Analysis of intestinal bacteria for patients with pancreatic exocrine secretion for precision medicine - Analysis of intestinal bacteria for patients with pancreatic exocrine secretion for precision medicine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034095

Enrollment

100

Registered

2018-12-01

Start date

2018-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pancreatitis, autoimmune pancreatitis, postoperative pancreatic, pancreatic exocrine insufficiency

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: For patients who perform endoscopic ultrasonography for each pancreatic disease at our hospital, aged 20 to 75 years old and consent this study.

Exclusion criteria

Exclusion criteria: Patients who have progressive disease such as malignant tumor, judged that the doctor inappropriate incorporation into this study, took antibiotics within 4 weeks

Design outcomes

Primary

Measure	Time frame
Comparison of mucosal micorobiota on digestive tract with pancreatic exocrine dysfunction or not	—

Secondary

Measure	Time frame
Comparison of mucosal micorobiota on digestive tract before and after administration to patients with pancreatic exocrine function disorder	—

Countries

Japan

Contacts

Public ContactSakagami Junichi

Kyoto Prefectural University of Medicine Gastroenterology and Hepatology

junichi@koto.kpu-m.ac.jp0752515111

Outcome results